Allergen-specific immunotherapy can prevent disease progression in the long term by tolerance development in allergic diseases. However, to achieve sustainable effects, long-term therapy is required, which requires a certain degree of adherence on the part of the patient. However, data show that treatment dropout rates are sometimes substantial. Which factors could be decisive for this, or how adherence can be promoted, is a much-discussed practice-relevant topic, on which there are numerous smaller and larger studies.
This content is machine-translated. Please contact us if you need professional translation services.
- HAUSARZT PRAXIS
- InFo PNEUMOLOGIE & ALLERGOLOGIE